Galapagos NVGalapagos NVGalapagos NV

Galapagos NV

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.76 B‬EUR
−4.315EUR
‪74.08 M‬EUR
‪275.65 M‬EUR
‪44.54 M‬
Beta (1Y)
0.80
Employees (FY)
704
Change (1Y)
−419 −37.31%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About Galapagos NV


CEO
Henry O. Gosebruch
Website
Headquarters
Mechelen
Founded
1999
ISIN
BE0003818359
FIGI
BBG000GD4QH3
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Check out other big names from the same industry as GXE.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Galapagos NV stocks are traded under the ticker GXE.
We've gathered analysts' opinions on Galapagos NV future price: according to them, GXE price has a max estimate of 44.80 EUR and a min estimate of 18.70 EUR. Watch GXE chart and read a more detailed Galapagos NV stock forecast: see what analysts think of Galapagos NV and suggest that you do with its stocks.
GXE reached its all-time high on Feb 19, 2020 with the price of 248.400 EUR, and its all-time low was 4.675 EUR and was reached on Aug 8, 2011. View more price dynamics on GXE chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Galapagos NV financials in yearly and quarterly reports right on TradingView.
Galapagos NV is going to release the next earnings report on Nov 5, 2025. Keep track of upcoming events with our Earnings Calendar.
GXE earnings for the last quarter are −1.58 EUR per share, whereas the estimation was −0.20 EUR resulting in a −692.70% surprise. The estimated earnings for the next quarter are −0.30 EUR per share. See more details about Galapagos NV earnings.
Galapagos NV revenue for the last quarter amounts to ‪65.29 M‬ EUR, despite the estimated figure of ‪69.99 M‬ EUR. In the next quarter, revenue is expected to reach ‪67.96 M‬ EUR.
GXE net income for the last quarter is ‪−105.75 M‬ EUR, while the quarter before that showed ‪−153.40 M‬ EUR of net income which accounts for 31.07% change. Track more Galapagos NV financial stats to get the full picture.
No, GXE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 4, 2025, the company has 704 employees. See our rating of the largest employees — is Galapagos NV on this list?
Like other stocks, GXE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Galapagos NV stock right from TradingView charts — choose your broker and connect to your account.